Brief Communication


Nature Neuroscience 7, 493 - 494 (2004)
Published online: 18 April 2004 | doi:10.1038/nn1226

Orexigen-sensitive NPY/AgRP pacemaker neurons in the hypothalamic arcuate nucleus

Marco van den Top1, Kevin Lee1, Andrew D Whyment1, Andrew M Blanks1 & David Spanswick1


The hypothalamic arcuate nucleus (ARC) integrates and responds to satiety and hunger signals and forms the origins of the central neural response to perturbations in energy balance. Here we show that rat ARC neurons containing neuropeptide Y (NPY) and agouti-related protein (AgRP), which are conditional pacemakers, are activated by orexigens and inhibited by the anorexigen leptin. We propose a neuron-specific signaling mechanism through which central and peripheral signals engage the central neural anabolic drive.


Central and peripheral signals involved in the maintenance of energy homeostasis, including leptin1, insulin2, ghrelin3 and orexin4, have been shown to modulate electrical activity of ARC neurons. It is poorly understood, however, how ARC neurons integrate and formulate appropriate output responses to these signals. In addition, the membrane mechanisms mediating these effects and the functional differentiation between neurons targeted by these signals (as suggested by the heterogeneity of projections and diversity of chemical phenotype5) remain to be determined.

We made electrophysiological recordings in brain slices from adult Wistar rats (Supplementary Methods online) to investigate how ARC neurons integrate central and peripheral signals indicating energy status. We identified a functionally and pharmacologically distinct subpopulation of ARC neurons, henceforth referred to as ARC pacemaker neurons. ARC pacemaker neurons were located in the medial ARC proximal to the third ventricle, an area known to contain NPY- and AgRP-expressing neurons that are activated by fasting. Morphologically these neurons are characterized by small, round cell bodies (diameter 13.4 plusminus 1.2 mum; n = 8) with 1–3 primary dendrites (Fig. 1a). Chemical phenotype was investigated using single-cell RT-PCR, which showed that these neurons express NPY and AgRP (n = 3; Fig. 1b). ARC pacemaker neurons showed a combination of several unique membrane properties compared to other ARC neurons, including anomalous inward rectification (IAN; voltage-dependent potassium conductances activated at potentials more negative than roughly -80 mV) and a transient outward rectifying conductance (ITR). ITR manifest as a delayed return to rest of the response to negative current injection (Fig. 1c). Functionally, ITR conductances are voltage-dependent potassium conductances that regulate neuronal firing frequency. The mean resting membrane potential and input resistance of these neurons was -48.3 plusminus 1.4 mV and 1,286 plusminus 116 MOmega, respectively (n = 33). Notably, and in contrast to other cell types in the ARC (n = 88), the orexigenic signals ghrelin (100–500 nM) and orexin (50–200 nM) induced characteristic pacemaker activity (n = 15). Pacemaker activity comprised of regular bursts of action potentials corresponding with underlying oscillations in membrane potential (Fig. 1d). Orexigen-induced pacemaker activity was sustained, persisting up to 30 min after exposure to the orexigen. The frequency and amplitude of orexigen-induced membrane potential oscillations underlying burst firing were 0.041 plusminus 0.002 Hz and 7.2 plusminus 1.8 mV (n = 10), respectively. This is within a range reported previously for the release of neuropeptides from hypothalamic neurons6, 7. The membrane potential oscillations underlying pacemaker activity persisted in TTX (n = 7; Fig. 1e,f) suggesting mediation through intrinsic cellular mechanisms. Orexin and ghrelin applied to the same AP neurons revealed induction of membrane potential oscillations by both neuropeptides (n = 3; data not shown). In contrast to orexigenic signals, the anorectic hormone leptin (50 nM, 30 min) induced a slow, progressive membrane hyperpolarization (-4.5 plusminus 2.2 mV) associated with a decrease in membrane resistance of 35.4 plusminus 6.9% and a cessation of all activity (n = 3; Fig. 2a). This effect of leptin was similar to that previously reported for ARC neurons, through activation of ATP-sensitive potassium channels1. Subsequent application of orexin restored membrane potential oscillations and pacemaker activity (Fig. 2a). The expression of the ghrelin receptor (growth hormone secretagogue receptor (GHSR)), the long form of the leptin receptor (Ob-Rb), and orexin receptors (OX1R and OX2R) were confirmed with single-cell RT-PCR (Fig. 1b).

Figure 1: Orexigen-sensitive pacemaker activity in ARC NPY/AgRP neurons.

Figure 1 : Orexigen-sensitive pacemaker activity in ARC NPY/AgRP neurons.

(a) Location (left) in the medial aspect of the arcuate nucleus, close to the third ventricle (3V) and morphology of ARC pacemaker neurons (ME, median eminence). (b) Using cytoplasmic contents from a single ARC pacemaker neuron, we detected mRNA encoding NPY, AgRP, orexin 1 receptor (OX1R), orexin 2 receptor (OX2R), leptin receptor (Ob-Rb), the growth hormone secretagogue receptor (GHSR) and beta-actin. These neurons did not express mRNA for proopiomelanocortin (POMC) (Supplementary Methods and Supplementary Table 1 online). (c) Characteristic electrophysiological properties of ARC pacemaker neurons included IAN and ITR. (d) Pacemaker activity comprised bursts of action potentials (top) superimposed upon underlying oscillations in membrane potential (bottom). (e) Ghrelin-induced pacemaker activity in the absence and presence of TTX (1 muM). (f) Pacemaker activity induced by orexin in the absence and presence of TTX. All experiments were done in accordance with the guidelines of the Home Office and the University of Warwick Ethical Review Committee.

Full size image (73 KB)

Figure 2: Mechanisms underlying leptin-induced inhibition of and orexigen-induced activation of ARC pacemaker cells.

Figure 2 : Mechanisms underlying leptin-induced inhibition of and orexigen-induced activation of ARC pacemaker cells.

(a) Continuous recording showing the slow inhibitory action of leptin on ARC pacemaker neurons and subsequent induction of pacemaker activity by orexin. (b) Current-voltage relations in the presence of TTX. AP neurons were characterized by IAN, which is observed as an instantaneous fall in input resistance at negative membrane potentials, and ITR, observed as a delayed return to resting membrane potential at the offset of the response to hyperpolarizing current injection (top left). ITR was blocked by 4-AP (1 mM, top right) and IAN was sensitive to Ba2+ (100 muM, bottom left). The combination of these ion channel blockers revealed a rebound depolarization (IRD) at the offset of the response to negative current injection (bottom left), which was blocked by Ni2+ (200 muM, bottom right). (c) The role of these conductances in generating pacemaker activity was probed with Ni2+ and 4-AP. Samples of a continuous recording showing that orexin-induced oscillations were abolished in the presence of Ni2+ (left) and increased in frequency in the presence of 4-AP (right).

Full size image (92 KB)

The mechanisms intrinsic to these cells, engaged by ghrelin and orexin and underlying the generation of pacemaker activity, were investigated further using potassium and calcium channel blockers. Whole-cell current-voltage (I-V) relationships obtained from ARC pacemaker neurons showed expression of a barium-sensitive (100 muM) IAN and a 4-aminopyridine-sensitive (4-AP; 1 mM) ITR (n = 4; Fig. 2b). Pharmacological inhibition of ITR with 4-AP uncovered a rebound depolarization at the offset of the response to negative current injection, reminiscent of the nickel-sensitive, low-threshold, T-type calcium conductance reported in other central neurons and shown to be involved in generating pacemaker-like activity8. Similarly, in ARC pacemaker neurons, rebound depolarization was blocked by 100–200 muM nickel (n = 3; Fig. 2b). The role of T-type calcium conductances and ITR in generating pacemaker activity was then investigated. Nickel (100–200 muM) abolished membrane potential oscillations underlying pacemaker activity in all neurons tested (n = 3; Fig. 2c), suggesting this conductance is crucial for driving pacemaker activity. In TTX (1 muM), to eliminate indirect effects from other neurons, application of 1 mM 4-AP increased the frequency of oscillations from 34 plusminus 7 mHz in control to 52 plusminus 6 mHz (n = 3; Fig. 2c), suggesting ITR regulates the frequency of bursts.

The principal orexigenic drive from the ARC originates from NPY/AgRP-expressing neurons9, specific targets and sites of action of ghrelin and orexin10, 11, 12, 13, 14 and the anorexigen leptin. Differential release of neuropeptides in the hypothalamus is crucial for the maintenance of energy homeostasis, and both ghrelin- and orexin-induced increases in food intake involve activation of NPY-dependent signaling. In the present study, we demonstrate the presence of NPY/AgRP pacemaker neurons in the ARC, in which burst firing is conditionally induced by orexigenic signals and suppressed by the anorexigen leptin. Pacemaker activity was driven by low-threshold calcium conductances, and the frequency was modulated by a transient outwardly rectifying potassium conductance. The unique response induced in these NPY/AgRP-expressing ARC pacemaker neurons to orexigenic signals and their sensitivity to the anorectic hormone leptin indicates a role for these neurons in pathways controlling energy balance. The importance of activity patterning for neuropeptide release from hypothalamic neurons is well established, with burst firing being a more effective stimulus for peptide release than fast, repetitive firing patterns of activity15. Taken together, these data suggest that burst firing and pacemaker activity in NPY/AgRP neurons, induced by orexigenic signals and suppressed by anorexigens, are key to the release of these peptides. Thus we propose a new neuron-specific cellular signaling pathway by which satiety and hunger signals engage the central neural anabolic drive.

Note: Supplementary information is available on the Nature Neuroscience website.



Top

Acknowledgments

Financial support from the Biotechnology and Biological Sciences Research Council (BBSRC), the Foundation for Prader-Willi Research and British Heart Foundation (BHF) is gratefully acknowledged.

Competing interests statement:

The authors declare no competing financial interests.

Received 24 December 2003; Accepted 24 February 2004; Published online 18 April 2004.

Top

References

  1. Spanswick, D., Smith, M.A., Groppi, V.E., Logan, S.D & Ashford, M.L.J. Nature 390, 521–525 (1997). | Article | PubMed | ISI | ChemPort |
  2. Spanswick, D., Smith, M.A., Mirshamsi, S., Routh, V.H & Ashford, M.L. Nat. Neurosci. 3, 757–758 (2000). | Article | PubMed | ISI | ChemPort |
  3. Cowley, M.A. et al. Neuron 37, 649–661 (2003). | Article | PubMed | ISI | ChemPort |
  4. Burdakov, D., Liss, B. & Ashcroft, F.M. J. Neurosci. 23, 4951–4957 (2003). | PubMed | ISI | ChemPort |
  5. Chronwall, B.M. Peptides 6, 1–11 (1985). | Article | PubMed | ISI | ChemPort |
  6. Dutton, A. & Dyball, R.E. J. Physiol. 290, 433–440 (1979). | PubMed | ISI | ChemPort |
  7. Bicknell, R.J. & Leng, G. Neuroendocrinology 33, 295–299 (1981). | PubMed | ISI | ChemPort |
  8. Huguenard, J.R. Annu. Rev. Physiol. 58, 329–348 (1996). | Article | PubMed | ISI | ChemPort |
  9. Cummings, D.E. & Schwartz, M.W. Annu. Rev. Med. 54, 453–471 (2003). | Article | PubMed | ISI | ChemPort |
  10. Nakazato, M. et al. Nature 409, 194–198 (2001). | Article | PubMed | ISI | ChemPort |
  11. Wang, L., Saint-Pierre, D.H. & Taché, Y. Neurosci. Lett. 325, 47–51 (2002). | PubMed | ISI | ChemPort |
  12. Dube, M.G., Horvath, T.L., Kalra, P.S & Kalra, S.P. Peptides 21, 1557–1560 (2000). | Article | PubMed | ISI | ChemPort |
  13. Jain, M.R., Horvath, T.L., Kalra, P.S. & Kalra, S.P. Regul. Pept. 87, 19–24 (2000). | Article | PubMed | ISI | ChemPort |
  14. Yamanaka, A. et al. Brain Res. 859, 404–409 (2000). | Article | PubMed | ISI | ChemPort |
  15. Poulain, D.A. & Wakerley, J.B. Neuroscience 7, 773–808 (1982). | Article | PubMed | ISI | ChemPort |
  1. Department of Biological Sciences, Gibbet Hill Campus, University of Warwick, Coventry CV4 7AL, UK.

Correspondence to: David Spanswick1 e-mail: D.C.Spanswick@warwick.ac.uk

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Obesity Keeping hunger at bay

Nature News and Views (08 Aug 2002)


Extra navigation

Subscribe to Nature Neuroscience

Subscribe

Open Innovation Challenges

naturejobs

ADVERTISEMENT